{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:47:02Z","timestamp":1792622822228,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1038\/s41590-022-01410-z","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T17:04:11Z","timestamp":1675098251000},"page":"220-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The type I interferon antiviral response in the choroid plexus and the cognitive risk in COVID-19"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8135-7794","authenticated-orcid":false,"given":"Stefano","family":"Suzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8600-2001","authenticated-orcid":false,"given":"Afroditi","family":"Tsitsou-Kampeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4015-7507","authenticated-orcid":false,"given":"Michal","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"1410_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.1252945","volume":"346","author":"K Baruch","year":"2014","unstructured":"Baruch, K. et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 346, 89\u201393 (2014).","journal-title":"Science"},{"key":"1410_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbi.2015.06.008","volume":"49","author":"SD Mesquita","year":"2015","unstructured":"Mesquita, S. D. et al. The choroid plexus transcriptome reveals changes in type I and II interferon responses in a mouse model of Alzheimer\u2019s disease. Brain. Behav. Immun. 49, 280\u2013292 (2015).","journal-title":"Brain. Behav. Immun."},{"key":"1410_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12987-018-0102-9","volume":"15","author":"EG Stopa","year":"2018","unstructured":"Stopa, E. G. et al. Comparative transcriptomics of choroid plexus in Alzheimer\u2019s disease, frontotemporal dementia and Huntington\u2019s disease: implications for CSF homeostasis. Fluids Barriers CNS 15, 18 (2018).","journal-title":"Fluids Barriers CNS"},{"key":"1410_CR4","doi-asserted-by":"publisher","first-page":"757482","DOI":"10.3389\/fncel.2021.757482","volume":"15","author":"L Van Hoecke","year":"2021","unstructured":"Van Hoecke, L. et al. Involvement of the choroid plexus in the pathogenesis of Niemann\u2013Pick disease type C. Front. Cell. Neurosci. 15, 757482 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"1410_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.0461","author":"Y-H Liu","year":"2022","unstructured":"Liu, Y.-H. et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2022.0461 (2022).","journal-title":"JAMA Neurol."},{"key":"1410_CR6","doi-asserted-by":"publisher","first-page":"101044","DOI":"10.1016\/j.eclinm.2021.101044","volume":"39","author":"A Hampshire","year":"2021","unstructured":"Hampshire, A. et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine 39, 101044 (2021).","journal-title":"EClinicalMedicine"},{"key":"1410_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41467-017-00769-0","volume":"8","author":"A Deczkowska","year":"2017","unstructured":"Deczkowska, A. et al. Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner. Nat. Commun. 8, 717 (2017).","journal-title":"Nat. Commun."},{"key":"1410_CR8","first-page":"3025","volume":"26","author":"M Piras","year":"2022","unstructured":"Piras, M. et al. Strong ACE-2 expression in the choroidal vessels: do high choroid plexuses serve as a gateway for SARS-CoV-2 infection on the human brain? Eur. Rev. Med. Pharmacol. Sci. 26, 3025\u20133029 (2022).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"1410_CR9","doi-asserted-by":"publisher","first-page":"573095","DOI":"10.3389\/fneur.2020.573095","volume":"11","author":"R Chen","year":"2020","unstructured":"Chen, R. et al. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front. Neurol. 11, 573095 (2020).","journal-title":"Front. Neurol."},{"key":"1410_CR10","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1111\/ene.15045","volume":"28","author":"G Cosentino","year":"2021","unstructured":"Cosentino, G. et al. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review. Eur. J. Neurol. 28, 3856\u20133865 (2021).","journal-title":"Eur. J. Neurol."},{"key":"1410_CR11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s42003-021-02856-x","volume":"4","author":"M Brady","year":"2021","unstructured":"Brady, M. et al. Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2. Commun. Biol. 4, 1318 (2021).","journal-title":"Commun. Biol."},{"key":"1410_CR12","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.stem.2020.10.001","volume":"27","author":"L Pellegrini","year":"2020","unstructured":"Pellegrini, L. et al. SARS-CoV-2 infects the brain choroid plexus and disrupts the blood\u2013CSF barrier in human brain organoids. Cell Stem Cell 27, 951\u2013961 (2020).","journal-title":"Cell Stem Cell"},{"key":"1410_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.stem.2020.09.016","volume":"27","author":"F Jacob","year":"2020","unstructured":"Jacob, F. et al. Human pluripotent stem cell-derived neural cells and brain organoids reveal SARS-CoV-2 neurotropism predominates in choroid plexus epithelium. Cell Stem Cell 27, 937\u2013950 (2020).","journal-title":"Cell Stem Cell"},{"key":"1410_CR14","doi-asserted-by":"publisher","first-page":"596439","DOI":"10.3389\/fnana.2020.596439","volume":"14","author":"F Deffner","year":"2020","unstructured":"Deffner, F. et al. Histological evidence for the enteric nervous system and the choroid plexus as alternative routes of neuroinvasion by SARS-CoV-2. Front. Neuroanat. 14, 596439 (2020).","journal-title":"Front. Neuroanat."},{"key":"1410_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","volume":"595","author":"AC Yang","year":"2021","unstructured":"Yang, A. C. et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 595, 565\u2013571 (2021).","journal-title":"Nature"},{"key":"1410_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13073-021-00933-8","volume":"13","author":"JF Fullard","year":"2021","unstructured":"Fullard, J. F. et al. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19. Genome Med. 13, 118 (2021).","journal-title":"Genome Med."},{"key":"1410_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02339-0","volume":"19","author":"S Jarius","year":"2022","unstructured":"Jarius, S. et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J. Neuroinflammation 19, 19 (2022).","journal-title":"J. Neuroinflammation"},{"key":"1410_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.immuni.2016.04.005","volume":"44","author":"T Blank","year":"2016","unstructured":"Blank, T. et al. Brain endothelial- and epithelial-specific interferon receptor chain 1 drives virus-induced sickness behavior and cognitive impairment. Immunity 44, 901\u2013912 (2016).","journal-title":"Immunity"},{"key":"1410_CR19","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.cell.2022.06.008","volume":"185","author":"A Fern\u00e1ndez-Casta\u00f1eda","year":"2022","unstructured":"Fern\u00e1ndez-Casta\u00f1eda, A. et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 185, 2452\u20132468 (2022).","journal-title":"Cell"},{"key":"1410_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","volume":"25","author":"C Yin","year":"2019","unstructured":"Yin, C. et al. ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat. Med. 25, 496\u2013506 (2019).","journal-title":"Nat. Med."},{"key":"1410_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature10357","volume":"477","author":"SA Villeda","year":"2011","unstructured":"Villeda, S. A. et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90\u201394 (2011).","journal-title":"Nature"},{"key":"1410_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8967","volume":"6","author":"K Baruch","year":"2015","unstructured":"Baruch, K. et al. Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer\u2019s disease pathology. Nat. Commun. 6, 7967 (2015).","journal-title":"Nat. Commun."},{"key":"1410_CR23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.devcel.2020.09.020","volume":"55","author":"J Cui","year":"2020","unstructured":"Cui, J. et al. Inflammation of the embryonic choroid plexus barrier following maternal immune activation. Dev. Cell 55, 617\u2013628 (2020).","journal-title":"Dev. Cell"},{"key":"1410_CR24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/glia.22786","volume":"63","author":"DJ Cox","year":"2015","unstructured":"Cox, D. J. et al. DNA sensors are expressed in astrocytes and microglia in vitro and are upregulated during gliosis in neurodegenerative disease. Glia 63, 812\u2013825 (2015).","journal-title":"Glia"},{"key":"1410_CR25","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/glia.23592","volume":"67","author":"A Nazmi","year":"2019","unstructured":"Nazmi, A. et al. Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression. Glia 67, 1254\u20131276 (2019).","journal-title":"Glia"},{"key":"1410_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature18626","volume":"535","author":"AJ Filiano","year":"2016","unstructured":"Filiano, A. J. et al. Unexpected role of interferon-\u03b3 in regulating neuronal connectivity and social behaviour. Nature 535, 425\u2013429 (2016).","journal-title":"Nature"},{"key":"1410_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.it.2016.01.006","volume":"37","author":"A Deczkowska","year":"2016","unstructured":"Deczkowska, A., Baruch, K. & Schwartz, M. Type I\/II interferon balance in the regulation of brain physiology and pathology. Trends Immunol. 37, 181\u2013192 (2016).","journal-title":"Trends Immunol."},{"key":"1410_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/alz.12399","volume":"18","author":"H-S Yang","year":"2022","unstructured":"Yang, H.-S. et al. Plasma IL-12\/IFN-\u03b3 axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimers Dement. 18, 645\u2013653 (2022).","journal-title":"Alzheimers Dement."},{"key":"1410_CR29","doi-asserted-by":"publisher","first-page":"603961","DOI":"10.3389\/fmed.2020.603961","volume":"7","author":"C Ruetsch","year":"2021","unstructured":"Ruetsch, C. et al. Functional exhaustion of type I and II interferons production in severe COVID-19 patients. Front. Med. 7, 603961 (2021).","journal-title":"Front. Med."},{"key":"1410_CR30","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao, B. et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front. Immunol. 11, 827 (2020).","journal-title":"Front. Immunol."},{"key":"1410_CR31","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1080\/14712598.2021.1887131","volume":"21","author":"PS Pezeshki","year":"2021","unstructured":"Pezeshki, P. S. & Rezaei, N. Immune checkpoint inhibition in COVID-19: risks and benefits. Expert Opin. Biol. Ther. 21, 1173\u20131179 (2021).","journal-title":"Expert Opin. Biol. Ther."},{"key":"1410_CR32","doi-asserted-by":"publisher","first-page":"e2111315118","DOI":"10.1073\/pnas.2111315118","volume":"118","author":"S Galv\u00e1n-Pe\u00f1a","year":"2021","unstructured":"Galv\u00e1n-Pe\u00f1a, S. et al. Profound Treg perturbations correlate with COVID-19 severity. Proc. Natl Acad. Sci. USA 118, e2111315118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1410_CR33","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/acn3.84","volume":"1","author":"LH Kasper","year":"2014","unstructured":"Kasper, L. H. & Reder, A. T. Immunomodulatory activity of interferon-beta. Ann. Clin. Transl. Neurol. 1, 622\u2013631 (2014).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1410_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","volume":"22","author":"K Baruch","year":"2016","unstructured":"Baruch, K. et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat. Med. 22, 135\u2013137 (2016).","journal-title":"Nat. Med."},{"key":"1410_CR35","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.immuni.2022.06.013","volume":"55","author":"T Aschman","year":"2022","unstructured":"Aschman, T., Mothes, R., Heppner, F. L. & Radbruch, H. What SARS-CoV-2 does to our brains. Immunity 55, 1159\u20131172 (2022).","journal-title":"Immunity"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01410-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01410-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01410-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T15:36:23Z","timestamp":1675265783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01410-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1410"],"URL":"https:\/\/doi.org\/10.1038\/s41590-022-01410-z","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S. is an inventor of the intellectual property that forms the basis for development of PD-L1 immunotherapy for AD.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}